Sagimet is pharmaceutical company developing novel therapeutics to treat important diseases .Our lead product candidate TVB-2640 is an oral, highly potent, selective and reversible, first-in-class FASN inhibitor.
Location: United States, California, Princeton-by-the-Sea
Employees: 11-50
Total raised: $105M
Founded date: 2006
Investors 3
| Date | Name | Website |
| 07.08.2021 | New Enterp... | nea.com |
| - | Altium Cap... | altiumcap.... |
| - | PFM Health... | pfmhealths... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.02.2021 | - | $80M | - |
| 05.08.2019 | Series E | $25M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 23.01.2024 | Gannex's Strategic Partner Sagimet Biosciences Announces Pos... | Denifanstat achieved statistically significant results on primary and multiple secondary endpoints i... | en.prnasia... |
| 22.01.2024 | Investigators fault Lilly plant for manufacturing issues | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 18.08.2021 | HistoIndex's Stain-free AI-based Digital Pathology Incorpora... | SINGAPORE, Aug. 18, 2021 /PRNewswire/ -- HistoIndex, a global leading artificial intelligence (AI) d... | en.prnasia... |
| 16.03.2021 | Sagimet Biosciences Receives Fast Track Designation from U.S... | prnewswire... | |
| 12.02.2021 | Sagimet Biosciences Raises $80M in Crossover Financing | Sagimet Biosciences, a San Mateo, Calif.-based clinical-stage biotechnology company, raised $80m in ... | finsmes.co... |
| 11.02.2021 | Sagimet Biosciences Inc. announced that it has received $80 ... | On February 11, 2021, Sagimet Biosciences Inc. closed the transaction. The company has received $10,... | marketscre... |
| 11.02.2021 | Sagimet Biosciences Raises $80 Million in Crossover Financin... | prnewswire... | |
| 11.02.2021 | Sagimet Biosciences : Raises $80 Million in Crossover Financ... | SAN MATEO, Calif., Feb. 11, 2021 /PRNewswire/ -- Sagimet Biosciences, a clinical-stage biotechnology... | marketscre... |
| 19.06.2020 | Ultragenyx’s ultra-expensive ultra-rare disease drug e... | → Ultragenyx’s Crysvita has scored its second FDA approval, earning the nod to treat bone soft... | endpts.com... |
| 05.08.2019 | Sagimet Biosciences Closes $25M Series E Financing | Sagimet Biosciences (FKA 3-V Biosciences), a San Mateo, Calif.-based clinical-stage biotechnology co... | finsmes.co... |